Skip to main content
logo
Scinai Immunotherapeutics Ltd. (TLV:BVXV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
49.30
-1.00 (-1.99%)
At close: Jan 18, 2018

Scinai Immunotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.211.310.66---
Revenue Growth
-2.41%99.24%----
Gross Profit
-4-2.65-0.58---
Operating Income
-8.44-7.54-8.64-9.71-11.06-10.86
Net Income
-3.17-8.31--6.5-5.8-8.21
Earnings Per Share
-1.13-3.56--16.64-30.74-80.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.961.661.964.8714.0817.37
Total Debt
3.52.272.0920.5621.5428.99
Net Cash (Debt)
-0.53-0.61-0.12-15.69-7.47-11.61
Net Cash Growth
------
Net Cash Per Share
-0.19-0.26-0.15-40.17-39.61-82.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.45-6.03-6.34-9.38-7.27-7.43
Capital Expenditures
-0.02-0.02-0.01-0.64-0.84-0.14
Free Cash Flow
-6.46-6.06-6.35-10.02-8.1-7.57
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--202.29%-88.15%---
Operating Margin
-695.31%-575.29%-1312.77%---
Pretax Margin
-261.37%-633.64%728.88%---
Profit Margin
-261.37%-633.64%----
FCF Margin
-532.46%-461.86%-964.59%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.791.884.34---